| Biotechnology Industry | Healthcare Sector | Mr. Xuheng Deng CEO | XSHE Exchange | CNE100005WX0 ISIN |
| CN Country | 3,184 Employees | 29 Apr 2026 Last Dividend | 10 Jun 2020 Last Split | - IPO Date |
Yili Chuanning Biotechnology Co.,Ltd. is a distinguished entity rooted in the bio-technological sphere within China, focusing extensively on the evolution and commercialization of biological fermentation technologies. Since its establishment in the year 2010, the company has anchored its operations in Yining, China, where it spearheads the development and application of cutting-edge biotechnological methods. The core of Yili Chuanning Biotechnology's operations lies in its steadfast dedication to innovation in the field of biotechnology, with a particular emphasis on the production of antibiotic intermediates through sophisticated fermentation processes.
Yili Chuanning Biotechnology offers a range of specialized products, primarily focusing on antibiotic intermediates. These products play a crucial role in the pharmaceutical industry, serving as foundational components for various antibiotics. Here's a closer look at the products offered: